OverviewChartNewsTraderScreen

JIANGSU HENGRUI MEDICINE CO LTD/  CNE0000014W7  /

Shanghai SE
2024-04-26  9:00:00 AM Chg. +1.31 Volume Bid9:00:02 AM Ask2024-04-26 High Low
45.61CNY +2.96% 34.28 mill.
Turnover: 1.55 bill.		 45.60Bid Size: 18,500 45.61Ask Size: 272,640 45.79 44.17
GlobeNewswire 03-27 Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regula...
GlobeNewswire 01-18 Elevar Therapeutics To Present Two Posters From Phase 3 CARES-310 Study at 2024 ASCO Gastrointestina...
GlobeNewswire 2023-10-23 Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...
GlobeNewswire 2023-10-17 Elevar Therapeutics and Jiangsu Hengrui Pharma Announce Global Commercialization Licensing Agreement...
GlobeNewswire 2023-10-17 Jiangsu Hengrui Pharma and Elevar Therapeutics Announce Global Commercialization Licensing Agreement...
GlobeNewswire 2023-09-21 Elevar Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference
GlobeNewswire 2023-09-19 Elevar Therapeutics Joins Benefactors Council of Blue Faery, Leading Hepatocellular Carcinoma Advoca...
GlobeNewswire 2022-03-24 Informa Pharma Intelligence Launches 30th Edition Pharma R&D Annual Review
GlobeNewswire 2021-12-30 BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
GlobeNewswire 2021-09-10 BeyondSpring Announces Second Quarter 2021 Financial Results and Provides a Corporate Update
GlobeNewswire 2021-08-26 BeyondSpring Announces Exclusive Commercialization and Co-development Agreement with Jiangsu Hengrui...
GlobeNewswire 2021-07-01 Arcutis Provides Update on Phase 2a Clinical Trial Evaluating ARQ-252 Cream as a Potential Treatment...
GlobeNewswire 2021-03-18 Arcutis Announces First Patient Enrolled in Phase 2a Clinical Trial Evaluating ARQ-252 as a Potentia...
GlobeNewswire 2020-10-26 Arcutis Completes Enrollment in Phase 1/2b Study Evaluating ARQ-252 in Chronic Hand Eczema
GlobeNewswire 2020-07-13 Arcutis Initiates Patient Enrollment in the Phase 2b Portion of the Phase 1/2b Study Evaluating ARQ-...
GlobeNewswire 2020-04-21 Arcutis Announces Enrollment of First Patient in Phase 1/2b Study of ARQ-252 in Patients with Chroni...
Newsfile Corp 2019-11-08 Novaliq and Jiangsu Hengrui Medicine Announce a Strategic Collaboration in Ophthalmology for the Eye...
GlobeNewswire 2019-09-12 Investigation Report on China's Pegaspargase Market, 2019-2023
GlobeNewswire 2019-01-09 China's Irbesartan Market Report, 2018-2022: Sales Value of Irbesartan on the Rise After it Entered ...
GlobeNewswire 2018-09-19 Antibody Discovery Services and Platforms Market, 2028
GlobeNewswire 2018-08-27 Global PD-1 and PD-L1 Inhibitors Market 2018-2022 - Accelerated Approval of New PD-1 and PD-L1 Inhib...
GlobeNewswire 2018-06-20 China Sevoflurane Investigation Report 2018: 2013-2017 Market Share & 2018-2022 Market Prospects
GlobeNewswire 2018-06-05 Asia-Pacific Breast Cancer Therapeutics Markets Report 2017-2024
GlobeNewswire 2018-05-08 TG Therapeutics, Inc. Provides Business Update and Reports First Quarter 2018 Financial Results
GlobeNewswire 2018-01-08 TG Therapeutics and Jiangsu Hengrui Medicine Announce Global License Agreement for Development and C...